THERMO FISHER SCIENTIFIC INC. cotiza a 662.24 USD y tiene una capitalización bursátil de $244.9B. En los últimos 12 meses ha facturado $46.3B con un margen de flujo de caja libre del 14.1%. Cotiza a 33.5 veces su flujo de caja libre (P/FCF) y a un PER de 35.1. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services internationally. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma …
| Periodo | 2026-10 | 2026-07 | 2026-04 | 2026-01 |
|---|---|---|---|---|
| Real | — | $6.03 | $5.44 | $6.57 |
| Estimado | $6.40 | $5.71 | $5.24 | $6.45 |
| Sorpresa | — | +5.6% | +3.8% | +1.9% |
| Métrica | TMO | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | 17.4% | -38.6% | +56.0% |
| Net Margin | 15.1% | -33.6% | +48.6% |
| FCF Margin | 14.1% | -13.9% | +28.0% |
| ROE | 12.6% | -40.4% | +53.0% |
| ROA | 6.1% | -32.0% | +38.1% |
| Current Ratio | 1.89 | 2.84 | -0.95 |
| Debt / Equity | 0.73 | 0.28 | +0.45 |